Biotechnology

Nanowalls, nanobridges, nano "jungle gyms": it could seem the description of a Lilliputian village, but these are actual 3D-printed components with tremendous potential applications in nanoelectronics, smart materials and biomedical devices.

ClearUP is a healthcare innovation within the emerging category of bioelectronic medicine. It uses low-level electrical stimulation, or microcurrent waveform, to treat allergic rhinitis.

The 6th Innovations in Large-Area Electronics Conference (innoLAE) returns to the Wellcome Genome Campus Conference Centre, Cambridge, UK on 21-22 January 2020, to deliver a programme highlighting the most innovative and exciting aspects of large-area electronics (LAE) - a new way of making electronics which includes printable, flexible, plastic, organic and bio- electronics.

Researchers have developed a way to 3D print living skin, complete with blood vessels. The advancement is a significant step toward creating grafts that are more like the skin our bodies produce naturally.

Feinstein Institutes for Medical Research scientists published a review of a bioelectronic medicine strategy to treat hemorrhagic shock.

Key themes in the world of plant-based and cultured meat

Clinical trial results of an investigational, non-invasive medical device for the treatment of spasticity in patients having experienced a stroke. Trans-spinal direct current stimulation and peripheral nerve direct current stimulation significantly reduced upper limb spasticity in participants who experienced a stroke.

The concept of using cell culture to grow meat products has drawn much hype in recent years, with cultured meat companies claiming they could produce food products identical to traditional meat at a fraction of the cost and environmental impact. This article introduces cultured meat, describing the underlying science, technology and the main challenges associated with cultured meat.

FemPulse Corporation, a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of overactive bladder in women, announced that the first participant has been enrolled in the Company's clinical trial evaluating physiological responses to therapy delivered with the FemPulse System.